GL1X · GenesisL1 explorer

MolNFT v1 · #51653 · protein

Crystallographic structure of levansucrase from bacillus subtilis mutant S164A

2VDT: “Crystallographic structure of levansucrase from bacillus subtilis mutant S164A”. X-ray diffraction, 1 ligand (CA), 2 pockets (best druggability 0.55). MolNFT v1 #51653 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
2VDT
Type
protein
Length
439 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Levansucrase
EC
2.4.1.10
UniProt
P05655
Ligands
CA
Pockets
2 · best druggability 0.55

Structure

x-ray diffraction · 1 distinct chain · 12% helix, 32% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ALevansucrase (EC 2.4.1.10)protein43912% helix, 32% strandP05655

Ligands and binding sites

  • CA · Calcium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12320.550.7831empty
2550.250.7315empty

Compared structures

  • 2VDT · Crystallographic structure of Levansucrase from Bacillus subtilis mutant S164A · the same entry in another collection · chain A against A, TM-score 1.00
  • P05655 · AlphaFold monomer V2.0 prediction for levansucrase (P05655) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.